U.S. Senator Ron Wyden (D-OR) has introduced the Cannabinoid Safety and Regulation Act (CSRA), a bill designed toto establish national standards to “protect public health and safety and keep cannabis products out of the hands of children”.

The CSRA would establish a national age restriction to prevent those under 21 from purchasing hemp-derived cannabis products, but it would not ban these products for those 21 and older.
The legislation would require that all hemp-derived products are tested for safety and are manufactured using clean and safe processes. The CSRA would require truth in labeling, and would require the Food and Drug Administration (FDA) to recall or ban any cannabis products with dangerous chemicals or additives.
Continue reading




The research, conducted by a team at the University of Alberta, examined how Cannabistilbene I influences cytochrome P450 (CYP) enzymes and arachidonic acid (AA) metabolic pathways, both of which play crucial roles in heart function and hypertrophy. The study is titled Effect of Cannabistilbene I in Attenuating Angiotensin II-Induced Cardiac Hypertrophy: Insights into Cytochrome P450s and Arachidonic Acid Metabolites Modulation.






